• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞相关mRNA的表达作为肝细胞癌的预后标志物

Expression of Cancer Stem Cell-associated mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.

作者信息

Sakabe Tomohiko, Azumi Junya, Umekita Yoshihisa, Toriguchi Kan, Hatano Etsuro, Hirooka Yasuaki, Shiota Goshi

机构信息

Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics, Graduate School of Medicine, Tottori University, Yonago, Japan.

Division of Organ Pathology, Department of Pathology, Faculty of Medicine, Tottori University, Yonago, Japan.

出版信息

Anticancer Res. 2017 Sep;37(9):4881-4888. doi: 10.21873/anticanres.11897.

DOI:10.21873/anticanres.11897
PMID:28870909
Abstract

BACKGROUND/AIM: Cancer stem cells (CSCs) are associated with prognosis of hepatocellular carcinoma (HCC). In our previous study, we created cDNA microarray databases on the CSC population of human HuH7 cells. In the present study, we identified genes that might serve as prognostic markers of HCC by employing existing databases.

MATERIALS AND METHODS

Expressions of glutathione S-transferase pi 1 (GSTP1), lysozyme (LYZ), C-X-C motif chemokine ligand 5 (CXCL5), interleukin-8 (IL8) and dickkopf WNT signaling pathway inhibitor 1 (DKK1), the five most highly expressed genes in the CSC cDNA microarray databases, were examined in 99 patients with HCC by real-time polymerase chain reaction (qRT-PCR), and their clinical significance was analyzed.

RESULTS

The Kaplan-Meier analysis showed that both overall and cancer-specific survival were significantly longer in patients with low DKK1 expression than in those with high DKK1 expression. The multivariate analysis revealed that overall survival was negatively associated with albumin and positively associated with alkaline phosphatase (ALP), serosal invasion and stage, and cancer-specific survival was positively associated with ALP, portal vein invasion and DKK1 mRNA.

CONCLUSION

Expression of CSC-associated DKK1 mRNA might be an unfavorable prognostic marker for patients with HCC.

摘要

背景/目的:癌症干细胞(CSCs)与肝细胞癌(HCC)的预后相关。在我们之前的研究中,我们创建了关于人HuH7细胞CSC群体的cDNA微阵列数据库。在本研究中,我们通过利用现有数据库鉴定了可能作为HCC预后标志物的基因。

材料与方法

通过实时聚合酶链反应(qRT-PCR)检测了CSC cDNA微阵列数据库中表达最高的五个基因,即谷胱甘肽S-转移酶pi 1(GSTP1)、溶菌酶(LYZ)、C-X-C基序趋化因子配体5(CXCL5)、白细胞介素-8(IL8)和Dickkopf WNT信号通路抑制剂1(DKK1)在99例HCC患者中的表达情况,并分析了其临床意义。

结果

Kaplan-Meier分析显示,DKK1低表达患者的总生存期和癌症特异性生存期均显著长于DKK1高表达患者。多因素分析显示,总生存期与白蛋白呈负相关,与碱性磷酸酶(ALP)、浆膜侵犯和分期呈正相关,癌症特异性生存期与ALP、门静脉侵犯和DKK1 mRNA呈正相关。

结论

CSC相关的DKK1 mRNA表达可能是HCC患者不良预后的标志物。

相似文献

1
Expression of Cancer Stem Cell-associated mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma.癌症干细胞相关mRNA的表达作为肝细胞癌的预后标志物
Anticancer Res. 2017 Sep;37(9):4881-4888. doi: 10.21873/anticanres.11897.
2
miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.miR-217 通过靶向 DKK1 激活 Wnt 信号通路促进肝癌肿瘤干细胞特性。
Oncol Rep. 2017 Oct;38(4):2351-2359. doi: 10.3892/or.2017.5924. Epub 2017 Aug 25.
3
Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.分泌型卷曲相关蛋白1(SFRP1)表达缺失与肝细胞癌预后不良相关。
Anticancer Res. 2016 Feb;36(2):659-64.
4
Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.DKK1表达升高与肝细胞癌中细胞质/细胞核β-连环蛋白积累及预后不良相关。
J Hepatol. 2009 May;50(5):948-57. doi: 10.1016/j.jhep.2008.11.020. Epub 2009 Jan 9.
5
ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.在人类肝细胞癌中,过表达醛脱氢酶1A1(ALDH1A1)的细胞是分化细胞,而非癌症干细胞或祖细胞。
Oncotarget. 2015 Sep 22;6(28):24722-32. doi: 10.18632/oncotarget.4406.
6
Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.miR-137 在肝细胞癌患者中的预后相关性。
Liver Int. 2017 Feb;37(2):271-279. doi: 10.1111/liv.13213. Epub 2016 Aug 16.
7
Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.PRRX1的下调赋予肝癌干细胞样特性并预示预后不良。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1402-9. doi: 10.1245/s10434-014-4242-0. Epub 2014 Nov 18.
8
Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.Dickkopf-1的过表达通过促进癌症转移和复发,预示原位肝移植术后肝细胞癌患者的预后不良。
Med Oncol. 2014 Jul;31(7):966. doi: 10.1007/s12032-014-0966-8. Epub 2014 May 31.
9
"Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.人类肝细胞癌中的“纤维巢”表达与不良临床预后相关的Wnt诱导基因特征。
Int J Biochem Cell Biol. 2016 Dec;81(Pt A):195-207. doi: 10.1016/j.biocel.2016.08.017. Epub 2016 Aug 18.
10
Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma.肝癌干细胞标志物颗粒体蛋白-上皮素前体和β-连环蛋白的表达与肝细胞癌复发相关。
Oncotarget. 2016 Apr 19;7(16):21644-57. doi: 10.18632/oncotarget.7803.

引用本文的文献

1
Tumor-derived CXCL5 promotes 5-fluorouracil resistance in colorectal cancer cells via p21 downregulation.肿瘤来源的CXCL5通过下调p21促进结肠癌细胞对5-氟尿嘧啶的耐药性。
Med Oncol. 2025 Jun 13;42(7):257. doi: 10.1007/s12032-025-02801-6.
2
Dickkopf-1 promotes tumor progression of gefitinib- resistant non-small cell lung cancer through cancer cell-fibroblast interactions.Dickkopf-1通过癌细胞与成纤维细胞的相互作用促进吉非替尼耐药非小细胞肺癌的肿瘤进展。
Exp Hematol Oncol. 2025 Mar 1;14(1):24. doi: 10.1186/s40164-025-00616-9.
3
Spatial analyses revealed CXCL5 and SLC6A14 as the markers of microvascular invasion in intrahepatic cholangiocarcinoma.
空间分析显示,CXCL5和SLC6A14是肝内胆管癌微血管侵犯的标志物。
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000597. eCollection 2025 Jan 1.
4
Dickkopf-1 Promotes Angiogenesis and is a Biomarker for Hepatic Stem Cell-like Hepatocellular Carcinoma.Dickkopf-1 促进血管生成,是肝干细胞样肝癌的生物标志物。
Int J Mol Sci. 2022 Mar 3;23(5):2801. doi: 10.3390/ijms23052801.
5
Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.用于肝细胞癌转化医学的蛋白质组学分析与人工智能
Biomedicines. 2021 Feb 6;9(2):159. doi: 10.3390/biomedicines9020159.
6
Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation.肝癌衍生生长因子刺激诱导的肝癌相关 microRNAs。
In Vivo. 2020 Sep-Oct;34(5):2297-2301. doi: 10.21873/invivo.12041.
7
Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer.癌胚抗原联合骨桥蛋白或 Dickkopf-1 在非小细胞肺癌中的诊断价值比较
Oncol Lett. 2020 Sep;20(3):3046-3052. doi: 10.3892/ol.2020.11846. Epub 2020 Jul 9.
8
Novel biomarkers for the management of chronic hepatitis B.用于慢性乙型肝炎管理的新型生物标志物。
Clin Mol Hepatol. 2020 Jul;26(3):261-279. doi: 10.3350/cmh.2020.0032. Epub 2020 Jun 15.
9
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target.肿瘤微环境中的 CXCL5/CXCR2 轴作为潜在的诊断生物标志物和治疗靶点。
Cancer Commun (Lond). 2020 Mar;40(2-3):69-80. doi: 10.1002/cac2.12010.
10
The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma: A meta-analysis.肝细胞癌患者治疗前血清碱性磷酸酶水平与预后的相关性:一项荟萃分析
Medicine (Baltimore). 2020 Mar;99(11):e19438. doi: 10.1097/MD.0000000000019438.